Afficher la notice abrégée

dc.creatorMakris, D.en
dc.creatorLazarou, S.en
dc.creatorAlexandrakis, M.en
dc.creatorKourelis, T. V.en
dc.creatorTzanakis, N.en
dc.creatorKyriakou, D.en
dc.creatorGourgoulianis, K. I.en
dc.date.accessioned2015-11-23T10:38:26Z
dc.date.available2015-11-23T10:38:26Z
dc.date.issued2008
dc.identifier10.1378/chest.07-2626
dc.identifier.issn123692
dc.identifier.urihttp://hdl.handle.net/11615/30520
dc.description.abstractBackground: T lymphocytes and especially the subpopulations of CD8+ cells are believed to have a key role in COPD pathophysiology, but there are only few data regarding the role of these cells in COPD exacerbation. Aim: We aimed to study prospectively changes of CD8+ T-lymphocyte subpopulations in the sputum of COPD patients at the onset of mild exacerbations and at a stable condition in order to provide further insight in the pathophysiology of the disease. Methods: Induced-sputum samples were collected from 24 COPD patients with median age of 52 years (interquartile range [IQR], 44 to 58 years) and FEV1 percentage of predicted of 78.05% (IQR, 75.8 to 80.1%) at the onset of mild exacerbations not requiring hospitalization and when stable. Inflammatory cells and T-lymphocyte subpopulations (CD4+, CD8+, and cells producing interferon [IFN]-γ or interleukin [IL]-4) were measured using flow cytometry and immunocytochemical methods. Results: A significant increase in sputum CD8+ T lymphocytes (p < 0.0001) and significant decreases in CD4+ T lymphocytes as well as in CD4+/CD8+ (p = 0.0001) and CD8+IFN-γ+/CD8+IL-4+ (p = 0.001), CD4+IFN-γ+/CD4+IL-4+ (p = 0.0003) sputum cells ratios were found decreased at the onset of exacerbations compared to stable condition. The changes in T-lymphocyte subpopulations were not associated with smoking history, demographic characteristics, or disease severity. Conclusion: The findings of the present study suggest that CD8+ lymphocytes are increased and potentially polarized toward a Tc2 profile in the airways of COPD patients at the onset of COPD exacerbations with respect to stable condition. The clinical impact of the observed phenomenon requires further investigation. Copyright © 2008 by American College of Chest Physicians.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-51649104325&partnerID=40&md5=631d805a1507e1caaa2b99ebf5c80abe
dc.subjectCOPDen
dc.subjectExacerbationsen
dc.subjectLymphocytesen
dc.subjectgamma interferonen
dc.subjectinterleukin 4en
dc.subjectadulten
dc.subjectarticleen
dc.subjectCD4+ T lymphocyteen
dc.subjectCD8+ T lymphocyteen
dc.subjectcell subpopulationen
dc.subjectchronic obstructive lung diseaseen
dc.subjectclinical articleen
dc.subjectdisease exacerbationen
dc.subjectdisease severityen
dc.subjecteosinophil counten
dc.subjectfemaleen
dc.subjectflow cytometryen
dc.subjectforced expiratory volumeen
dc.subjecthospitalizationen
dc.subjecthumanen
dc.subjecthuman cellen
dc.subjectimmune responseen
dc.subjectimmunocytochemistryen
dc.subjectinflammatory cellen
dc.subjectlymphocyte counten
dc.subjectmacrophageen
dc.subjectmaleen
dc.subjectneutrophil counten
dc.subjectpathophysiologyen
dc.subjectpriority journalen
dc.subjectsmokingen
dc.subjectsputumen
dc.subjectsputum analysisen
dc.subjectCD4-CD8 Ratioen
dc.subjectCD4-Positive T-Lymphocytesen
dc.subjectCD8-Positive T-Lymphocytesen
dc.subjectHumansen
dc.subjectInterferon Type IIen
dc.subjectInterleukin-4en
dc.subjectLymphocyte Subsetsen
dc.subjectMiddle Ageden
dc.subjectProspective Studiesen
dc.subjectPulmonary Disease, Chronic Obstructiveen
dc.subjectT-Lymphocytes, Cytotoxicen
dc.titleTc2 response at the onset of COPD exacerbationsen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée